Colorectal General Referral

This protocol should only be used where there is no suspicion of malignancy

If there is a degree of suspicion please see the guidelines below and refer through the Lanarkshire Cancer Referral Centre

Colorectal Cancer Referral Guideline

Risk-Based guidelines for Investigating Patients with Colorectal Symptoms

Patients with any of the following symptoms and associated symptoms should be referred urgently through the Lanarkshire SCI Gateway Cancer Referral Services. This will ensure that a patient pathway co-ordinator tracks the referral from the day it is sent..

Patients over 75 will be seen at the clinic first and will not be appointed straight to test.

Main SymptomAssociated SymptomAgePatient will be booked for
Rectal bleeding for > 6 week
Frequent and/or loose stools for 6 weeks
Constipation

Constipation

in isolation
in isolation
>75
<75

>50-74

<50

>50-74
<50
Outpatient clinic
Colonoscopy

Flexible Sigmoidoscopy and Barium Enema
Please refer using Routine Colorectal Guideline (below)
Flexible Sigmoidoscopy and Barium Enema
Please refer using Routine Colorectal Guideline (below)
Diarrhoea 3 or more loose or liquid stools/day for > 4 weeks>75
>50-74
<50
Outpatient clinic
Colonoscopy
Please refer using Routine Colorectal Guideline (below)
Palpable mass, right sided Abdominal mass or Rectal massAnyOutpatient clinic appointment
Iron deficiency Anaemia. UnexplainedUpper GI symptoms

in isolation male or postmenopausal female
in isolation male or postmenopausal female
Pre-menopausal female


<75

>75
Please refer using the Upper GI Suspected Cancer Guidelines
Colonoscopy and gastroscopy

Outpatient clinic

Please refer using Routine Colorectal Guideline (below) or to Gastroenterology

Routine Colorectal Referral Guideline

Patients with any of the following symptoms and associated symptoms should be referred routinely through the Lanarkshire SCI Gateway to the colorectal specialty in the appropriate hospital.

Patients over 75 will be seen at the clinic first and will not be appointed straight to test

Main SymptomsAssociated symptomAgePatient will be booked for:
Rectal bleeding for > 6 weeksConstipation
in isolation
<50
<50
Flexible Sigmoidoscopy
Flexible Sigmoidoscopy
Diarrhoea 3 or more loose or liquid stools/day for > 4 weeks<50Outpatient clinic
Constipation recent change of bowel habit>75
>50-74

<50
Outpatient clinic
Flexible Sigmoidoscopy and Barium Enema
Outpatient clinic
Iron deficiency Anaemia. UnexplainedIn isolationPremenopausal femaleGastroenterology or Colorectal Outpatient Clinic

All patients who require direct referral to test should be:

  • Physically fit for bowel preparation
  • No Anal symptoms (pain, discomfort, itching, lump and prolapse)
  • No Large bowel investigations carried out in the last 2 years

Investigations

No examinations or investigations (other than abdominal and rectal examination ,Uamp;E (for patient safety with bowel prep) and FBC are recommended).

Chronic diarrhoea – recommended investigations are Uamp;E, FBC, CRP, TFT and faeces culture

FOB or CEA is not indicated and should not influence decision making in symptomatic patients.

Key Points:

Patients with the following symptoms are at very low risk of cancer and could be managed initially within Primary Care or referred non-urgently for assessment:

  • Rectal bleeding with anal symptoms
  • Change in bowel habit to decreased frequency of defaecation and harder stools.
  • Abdominal pain without clear evidence of intestinal obstruction.

Colorectal Cancer and Family History

Individuals who have a family history of colorectal cancer but who are asymptomatic may warrant investigations if their history meets the criteria outlined in the following table. If any of the criteria are fulfilled patients should be referred for risk assessment to:

Regional Genetics Service

Management of High Risk Groups

RiskCriteria for ScreeningScreeningAge of Screening
HighAt least three family members affected by CRC and one with endometrial cancer in at least two generations; one affected relative must be age ?50 years at diagnosis; one of the relatives must be a first degree relative of the other two

Gene carriers (HNPCC genes)

Untested primary relatives of gene carriers
Colonoscopy every 2 years

Discuss gynaecological screening for endometrial and ovarian cancer

Offer 2 yearly upper GI endoscopy for gastric cancer

Consideration needs to be given to other screening for other cancers which may occur in specific families and are part of the HNPCC spectrum
From 30 to 70 years (or 5 years younger than the youngest affected relative)

For stomach cancer from 50 to 70 years or 5 years younger than the youngest stomach cancer
MediumOne first degree relative affected by colorectal cancer when aged < 45 years;

or

Two affected first degree relatives (one less than 55 years);

or

Two (one CRC less than 55 years) or three affected individuals with colorectal or endometrial cancer who are first degree relatives of each other and one a first degree relative of consultand.
Single colonoscopy if normal findings

Single repeat colonoscopy
At 30-35 years and again at 55 years
LowAnyone not fulfilling medium or high risk criteriaReassure and encourage healthy lifestyle

GP to monitor
N/A

Hereditary Nonpolyposis Colorectal Cancer (HNPCC)
Sign revised edition – in press

HNPCC is an autosomal dominant condition caused by a mismatch repair gene mutation. Individuals carrying a mismatch repair gene mutation or fulfilling high risk criteria for HNPCC should be offered endoscopic screening starting in the twenties if possible and repeated every 2-3 years taking into account the patient’s general condition and uptake. Diagnosis requires:

At least three relatives with a HNPCC-associated cancer (colorectal, endometrial, small bowel, ureter or renal pelvis) (one of whom should be a first degree relative of the other two)

At least two consecutive generations should be affected

At least one should be diagnosed before age fifty years

Referral should be made to the Regional Genetics Service for consideration of Mismatch Repair Gene mutation analysis

Familial adenomatous polyposis (FAP)
Sign Revised edition – in press

FAP is an autosomal dominant condition caused by an APC gene mutation and characterised by the development of multiple adenomatous colorectal polyps and the subsequent development of one or more colorectal cancers. In patients with FAP, referral should be made to the Regional Genetics Service for consideration of APC Gene mutation analysis. For those at risk of FAP, determined either by a positive family history or on the basis of mutation analysis should be offered:

At least three relatives with a HNPCC-associated cancer (colorectal, endometrial, small bowel, ureter or renal pelvis) (one of whom should be a first degree relative of the other two)

Colonoscopy every 2-3 years and yearly sigmoidoscopy

Patients should be offered proctocolectomy with or without ileoanal reconstruction or total colectomy with ileorectal anaastomsis once adenomas have developed. Subsequent management should include lifelong survey

Other High Risk Groups

A number of chronic conditions require structured surveillance. These include:

Chronic Inflammatory Bowel Disease

Acromegaly

Peutz-Jeghers Syndromme

Juvenile Polyposis Coli


Reference: Scottish Referral Guidelines for Suspected Cancer. Scottish Executive 2007
SIGN Guideline 67 -Management of Colorectal Cancer
Lead Clinician Mr Alistair Brown, NHS Lanarkshire
Review Date Dec 2010